13FPulse
AC

ACAD ACADIA PHARMACEUTICALS INC

2026Q2 · CUSIP 004225108 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
346
Institutions that reported holding it to the SEC
Net increase in holders
+7
Last quarter 339 → now 346
How unusual is that
Above average
Stronger buying than 62% of US stocks
What the filings say, in one paragraph

346 funds held ACAD at the end of 2026Q2, up 7 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $1.1B(YoY +11.8%), the P/E is 13.0x, return on equity is 29.1%. ACAD has had 15 buying rushes in its history, and the price moved +2.4% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2013Q3: holders=136 2013Q4: holders=146 2014Q1: holders=166 2014Q2: holders=156 2014Q3: holders=155 2014Q4: holders=176 2015Q1: holders=185 2015Q2: holders=181 2015Q3: holders=181 2015Q4: holders=205 2016Q1: holders=207 2016Q2: holders=223 2016Q3: holders=228 2016Q4: holders=224 2017Q1: holders=219 2017Q2: holders=202 2017Q3: holders=206 2017Q4: holders=208 2018Q1: holders=197 2018Q2: holders=187 2018Q3: holders=181 2018Q4: holders=184 2019Q1: holders=197 2019Q2: holders=195 2019Q3: holders=230 2019Q4: holders=271 2020Q1: holders=243 2020Q2: holders=297 2020Q3: holders=265 2020Q4: holders=306 2021Q1: holders=271 2021Q2: holders=245 2021Q3: holders=237 2021Q4: holders=246 2022Q1: holders=260 2022Q2: holders=244 2022Q3: holders=223 2022Q4: holders=229 2023Q1: holders=233 2023Q2: holders=235 2023Q3: holders=247 2023Q4: holders=276 2024Q1: holders=267 2024Q2: holders=266 2024Q3: holders=257 2024Q4: holders=297 2025Q1: holders=320 2025Q2: holders=313 2025Q3: holders=334 2025Q4: holders=336 2026Q1: holders=339 2026Q2: holders=346 -54 -27 +0 +27 +54 122243364 13Q315Q116Q318Q119Q321Q122Q324Q125Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 15 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2025Q3 Top 20% +1.3% -12.7%
2025Q1 Top 10% +13.6% +9.2%
2024Q4 Top 20% +11.1% +25.0%
2023Q4 Top 20% -41.1% -37.2%
2023Q3 Top 20% +12.6% -31.6%
2022Q1 Top 20% +8.3% -5.3%
2020Q4 Top 20% -58.9% -66.8%
2020Q2 Top 5% +30.7% +26.9%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
187
Change in large funds
+16
Total value they hold
$4.2B
Funds buying for the first time
52
Funds that sold out entirely
45
Price change that quarter
+39.8%
Funds holding puts (bearish)
5
Funds holding calls (bullish)
7

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
13.0
EPS (TTM)
$2.23
EPS YoY
+67.7%
Revenue (TTM)
$1.1B
Revenue YoY
+11.8%
Net margin
33.4%
ROE
29.1%
Debt ratio
25.0%
FCF (TTM)
$146M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.09 2021-12-31: EPS -0.27 2022-03-31: EPS -0.70 2022-06-30: EPS -0.21 2022-09-30: EPS -0.17 2022-12-31: EPS -0.26 2023-03-31: EPS -0.27 2023-06-30: EPS 0.01 2023-09-30: EPS -0.40 2023-12-31: EPS 0.28 2024-03-31: EPS 0.10 2024-06-30: EPS 0.20 2024-09-30: EPS 0.20 2024-12-31: EPS 0.86 2025-03-31: EPS 0.11 2025-06-30: EPS 0.16 2025-09-30: EPS 0.42 2025-12-31: EPS 1.61 2026-03-31: EPS 0.02 2026-06-30: EPS 0.18 0M 154M 308M $M -0.77 0.50 1.77 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 16 9 49 90 202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-76M5M85M 20162017201820192020202120222023202420252026
Latest quarter $29M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.